Seqanswers Leaderboard Ad

Collapse

Announcement

Collapse
No announcement yet.
X
 
  • Filter
  • Time
  • Show
Clear All
new posts

  • Using DESeq2's VST

    I need to normalize some RNA-seq data (read counts) to obtain library-size normalized inputs for eQTL calling. The easiest option would be to simply calculate TPMs or FPKMs (i.e. divide by the total number of reads per library) but I thought it might actually be better to use DESeq2's variance stabilizing transformation for this. If I am reading the vignette correctly, this should not only scale the read counts by a better estimate of the library size, but also log them and result in a more stable variance across mean expression levels.

    Has anybody tried this before? Is there any reason why this would not be a good idea?

    An additional complication is that I have read counts at multiple conditions. Right now I am normalizing them all at the same time, using design = ~condition to tell DESeq which condition each sample is from. Is this okay or would it be better to normalize each condition individually?

    Here is my code:

    Code:
    library(DESeq2)
    cds = DESeqDataSetFromMatrix(data.in, colData = colData, design = ~condition)
    dds = DESeq(cds)
    vsd = varianceStabilizingTransformation(dds, blind = FALSE)
    data.out = assay(vsd)
    colnames(data.out) = colnames(data.in)

Latest Articles

Collapse

  • seqadmin
    Understanding Genetic Influence on Infectious Disease
    by seqadmin




    During the COVID-19 pandemic, scientists observed that while some individuals experienced severe illness when infected with SARS-CoV-2, others were barely affected. These disparities left researchers and clinicians wondering what causes the wide variations in response to viral infections and what role genetics plays.

    Jean-Laurent Casanova, M.D., Ph.D., Professor at Rockefeller University, is a leading expert in this crossover between genetics and infectious...
    09-09-2024, 10:59 AM
  • seqadmin
    Addressing Off-Target Effects in CRISPR Technologies
    by seqadmin






    The first FDA-approved CRISPR-based therapy marked the transition of therapeutic gene editing from a dream to reality1. CRISPR technologies have streamlined gene editing, and CRISPR screens have become an important approach for identifying genes involved in disease processes2. This technique introduces targeted mutations across numerous genes, enabling large-scale identification of gene functions, interactions, and pathways3. Identifying the full range...
    08-27-2024, 04:44 AM

ad_right_rmr

Collapse

News

Collapse

Topics Statistics Last Post
Started by seqadmin, 09-11-2024, 02:44 PM
0 responses
11 views
0 likes
Last Post seqadmin  
Started by seqadmin, 09-06-2024, 08:02 AM
0 responses
145 views
0 likes
Last Post seqadmin  
Started by seqadmin, 09-03-2024, 08:30 AM
0 responses
152 views
0 likes
Last Post seqadmin  
Started by seqadmin, 08-27-2024, 04:40 AM
0 responses
161 views
0 likes
Last Post seqadmin  
Working...
X